from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1083/-

LFCtreatmentdescriptionclass of inhibitor

-1.456

Amikacinug/mL Amikacintranslation

-2.407

Cap5-10ug/mL Capreomycintranslation

-1.816

Rox10-50 ug/mL Roxithromycintranslation

-0.400

SM2-5 ug/mL Streptomycintranslation

-0.439

Tet5-10 ug/mL Tetracyclinetranslation

-0.149

Rif0.2-5ug/mL Rifampicintranscription

-0.140

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.190

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.093

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.465

CPZ10-50 ug/mL Chlorpromazinerespiration

0.788

Clofazimine10-13 ug/mL Clofaziminerespiration

0.102

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.494

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.392

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.119

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.428

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.127

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.025

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.555

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.429

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.758

KCN5-20 ug/mL Potassium cyaniderespiration

0.938

NaN30.2-2 mM Sodium aziderespiration

-0.039

Nigericin50 uM Nigericinrespiration

0.183

TRC10-150 ug/mL Triclosanrespiration

0.594

TRZ10-25 ug/mL Thioridazinerespiration

-1.639

Valinomycin0.5-10 uM Valinomycinrespiration

0.606

ZnSO42 mM ZnSO4respiration

0.368

menadione6-10 ug/mL Menadionerespiration

0.220

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.141

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.335

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.196

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.114

NRP_1Non-replicating persistence stage 1dosRassociated

-0.229

Amp0.2mg/mL AmpicillincellWall

-0.042

Cephalexin20-100 ug/mL CephalexincellWall

0.763

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.001

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.597

EMB10-20 ug/mL EthambutolcellWall

0.440

Eta12-40 ug/mL EthionamidecellWall

0.259

INH0.2-0.4 ug/mL IsoniazidcellWall

0.452

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.555

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.325

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.082

BZA0.12 mg/mL BenzamidearomaticAmides

-1.027

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.095

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.642

H2O24 mM hydrogen peroxideDNAdamaging

-0.555

Levo10 ug/mL LevofloxacinDNAdamaging

0.069

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.941

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.559

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.031

UVUV-irradiationDNAdamaging

0.370

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.009

Antimycin12.5-50 ug/mL Antimycin A?

-0.200

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.109

PA_110-50 ug/mL Antitubercular compound PA-1?

0.209

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.195

PA8240.2-2 ug/mL PA-824?

1.307

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.123

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.071

Verapamil50 uM Verapamil?

0.179

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.248

methoxatin10-20 ug/mL Methoxatin?